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A B S T R A C T
Genomes are affected by a wide range of damage, which has resulted in the evolution of a number of widely
conserved DNA repair pathways. Most of these repair reactions have been described in the African trypanosome
Trypanosoma brucei, which is a genetically tractable eukaryotic microbe and important human and animal
parasite, but little work has considered how the DNA damage response operates throughout the T. brucei life
cycle. Using quantitative PCR we have assessed damage induction and repair in both the nuclear and mi-
tochondrial genomes of the parasite. We show differing kinetics of repair for three forms of DNA damage, and
dramatic differences in repair between replicative life cycle forms found in the testse fly midgut and the
mammal. We find that mammal-infective T. brucei cells repair oxidative and crosslink-induced DNA damage
more efficiently than tsetse-infective cells and, moreover, very distinct patterns of induction and repair of DNA
alkylating damage in the two life cycle forms. We also reveal robust repair of DNA lesions in the highly unusual
T. brucei mitochondrial genome (the kinetoplast). By examining mutants we show that nuclear alkylation da-
mage is repaired by the concerted action of two repair pathways, and that Rad51 acts in kinetoplast repair.
Finally, we correlate repair with cell cycle arrest and cell growth, revealing that induced DNA damage has
strikingly differing effects on the two life cycle stages, with distinct timing of alkylation-induced cell cycle arrest
and higher levels of damage induced death in mammal-infective cells. Our data reveal that T. brucei regulates the
DNA damage response during its life cycle, a capacity that may be shared by many microbial pathogens that exist
in variant environments during growth and transmission.
1. Introduction
Trypanosoma brucei is the causative agent of sleeping sickness in
humans and nagana in livestock. The parasite has a complex life cycle,
undergoing multiple changes as it develops within and transmits be-
tween mammal hosts and the testse fly vector. Such changes include
alterations in metabolism [1], composition of surface proteins [2], and
organelle organization inside the cell body [3]. Within testse flies
(Glossina genus), T. brucei differentiates between replicative and non-
replicative forms in both the digestive system and in the salivary glands
[4]. Currently, only replicative procyclic forms (PCF) cells from the fly
midgut are routinely grown and genetically manipulated in culture
(Fig. 1A). Non-replicative metacyclic form cells in the tsetse salivary
gland establish infections in mammals, after fly feeding, by differ-
entiating into the replicative long slender bloodstream form (BSF),
which can also be routinely cultured and modified (Fig. 1A). BSF cell
survival in the mammal critically depends on expression of a ‘coat’
composed of a single variant surface glycoprotein (VSG), which is
periodically switched to an antigenically distinct VSG type to thwart
clearance by the host adaptive immune response [5–7]. In contrast, PCF
cells do not require VSG antigenic variation and, instead, they express
different forms of procyclin on their surface [8]. Despite these differ-
ences in the cell surface proteome, allied to alterations in cell biology
and metabolism, both PCF and BSF cells appear to function to establish
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and maintain infections through growth by mitotic division. None-
theless, comparisons of the two life cycle stages suggest differences in
cell cycle timing and in checkpoints [9,10]. What is less clear is if these
growth differences extend to changes in the use or execution of the DNA
damage response, which is critical for the successful transmission of
intact, functional genomes from parent to progeny. In all kinetoplastids,
maintenance of the unusual mitochondrial genome, termed the kine-
toplast (Fig. 1B, discussed below), is likely also to require DNA repair
pathways, which are poorly characterized relative to the nucleus
(Fig. 1C).
Antigenic variation has provided a motivation for understanding the
DNA damage response in T. brucei, since the available evidence suggests
this process is intimately linked to homologous recombination (HR)
[11], which is universally conserved throughout life and thought to
mainly act in the repair of DNA double strand breaks (DSBs) and re-
plication fork stalls [12]. A switch in the VSG coat is primarily executed
by recombination reactions that replace the VSG gene present in ac-
tively transcribed VSG expression site with a VSG gene from a silent
archive of> 1000 genes or pseudogenes [6]. Most VSG recombination
occurs by gene conversion, and mutation of many components of the
HR pathway, including RAD51 [13], BRCA2 [14], RAD51-related pro-
teins [15], Topo III-α [16], and a RECQ helicase and putative inter-
actors [17], has been described as altering the rate and profile of VSG
gene conversion in BSF T. brucei, as well as altering general genome
repair. However, these studies have mainly been limited to intact silent
VSGs, and little is known about the reaction(s) that can generate novel
mosaic VSGs through segmental gene conversion of intact and pseudo
VSG genes variation [18]. In addition, most living organisms perform
DSB repair not simply by HR, but also by end-joining of the DSB. Most
commonly, such direct repair of the broken molecule occurs by non-
homologous end joining (NHEJ), which relies on a dedicated ma-
chinery, including the DSB binding factor Ku [19]. DSB repair in T.
brucei and related kinetoplastid parasites appears to rely mainly on HR,
perhaps because the parasites lack NHEJ: key factors are missing
[20–22], and targeted assays to follow repair of an induced DSB (by I-
SceI [23] or CRISPR-Cas9 [24,25] cleavage) have failed to detect NHEJ.
Microhomology-mediated end-joining (MMEJ; sometimes called alter-
native NHEJ) can be detected in some cases [23,26], but the conditions
in which this reaction is utilized, and the enzymatic machinery in-
volved, have not been extensively investigated. Whether MMEJ con-
tributes to VSG switching is unknown.
Though most experimental efforts have addressed the role of re-
combination repair in T. brucei, further DNA repair pathways operate,
or can be predicted to do so (Fig. 1C). Genetic and biochemical studies
clearly demonstrate the action of Nucleotide Excision Repair (NER)
[27–29], Base Excision Repair (BER) [30–38] and Mismatch Repair
(MMR) in T. brucei [39–44]. In contrast, further T. brucei DNA repair
pathways are less well explored, including Direct Reversion Repair (DR)
[45], Interstrand Crosslink Repair (ICL repair) [29,46] and Translesion
Synthesis (TLS) [47]. In all cases, the potential that trypanosomatid
repair pathways might differ from counterpart pathways in model eu-
karyotes, reflecting parasite-specific biology, is relatively poorly un-
derstood. One validated example of such a difference is specialization of
NER due to near universal nuclear multigenic transcription, but even
Fig. 1. Trypanosoma brucei life cycle stages examined in this study, and aspects of their genome maintenance A) The two life cycle forms used in this study are
shown: the replicative long slender bloodstream form (BSF) and the replicative procyclic form (PCF), which are found, respectively, in the mammalian bloodstream
and tsetse fly midgut. Cellular hallmarks of the two life cycle stage are presented below their respective cartoons (k, kinetoplast; n, nucleus; VSG, variant surface
glycoprotein). B) Current model of kinetoplast structure and replication in T. brucei [83]. Minicircles and maxicircles are concatenated and organized parallel to the
axis of the kinetoplast disk. Covalently closed minicircles (circular shapes) are detached from the kinetoplast disk to initiate replication as θ structures (θ shapes).
DNA polymerases, as well as other proteins involved in kDNA replication, are represented by black spheres. After replication, gapped or nicked progeny minicircles
migrate to antipodal sites (grey spheres), where gap filling by DNA polymerase β, sealing by ligase kβ, and linkage to the kDNA network by topoisomerase II occurs.
Further gap filling and sealing can occur at the kinetoplast disk by the action of DNA polymerase β-PAK and ligase kα. C) Overview of DNA repair pathways identified
and/or characterized in the nucleus (nDNA) or kinetoplast (kDNA) of BSF or PCF trypanosomes; DNA repair pathways are abbreviated as in the text, and numbers are
references cited in the text. Cartoons were modified from [83–85].
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here the details remain incompletely resolved [29]. A further potential
source of novelty lies in the highly unusual structure of the genome of
the single copy trypanosomatid mitochondrion, or kinetoplast (Fig. 1B).
The kinetoplast is composed of a network of circular, concatemerized
DNA molecules of ∼1 and 23 kb known, respectively, as minicircles
and maxicircles. Maxicircles are present in 30–50 copies and have
homology with the mitochondrial genome of other eukaryotes, whereas
minicircles are present in several thousands of copies and encode RNAs
specialized for mitochondrial RNA editing [48]. Mitochondrial tar-
geting of DNA polymerases normally involved in nuclear BER or TLS
[48] suggest the action of some repair pathways in the kinetoplastid, or
co-option of repair components for replication, but a full description of
kinetoplastid repair capacity is lacking.
A further potential source of T. brucei and trypanosomatid DNA
repair specialization, for which there is limited information, concerns
the signaling or regulation of the pathways, and whether the repair
mechanisms are differentially modulated throughout the parasite’s de-
velopmental programmes. While high throughput phenotyping of T.
brucei has revealed a range of activities involved in alkylation damage
repair [49], such work has so far been limited to BSF cells and only a
small number of focused experiments have compared repair in BSF and
PCF cells. For instance, TLS DNA Polymerase Kappa (Polκ) and the
homolog of Structural Maintenance of Chromosome 1 (SMC1, which
promotes chromosomal stability in yeast by channeling HR between
sister chromatids) are essential for BSF cells but not for PCF. Con-
versely, the T. brucei homolog of DNA Damage Inducible Protein 1
(DDI1-like) is essential for PCF cells but not for BSF [50]. Deletion of
BRCA2, a protein which acts in HR by promoting Rad51 loading onto
RPA-coated single-stranded DNA stretches, is non-lethal in both life
cycle stages, but has a higher impact on BSF fitness than it has in PCF,
since it causes observable chromosomal instability in the former but not
in the latter [51]. Moreover, deletion of MSH2, which plays a central
role in MMR, generates distinct phenotypes in BSF and PCF cells: where
BSF MSH2 null mutants display increased sensitivity to hydrogen per-
oxide, the same mutants increase PCF cell tolerance to oxidative stress,
even though both life stages display MMR deficiency [43].
Though the above data indicate developmental stage variation in T.
brucei genome stability pathways, it is less clearly understood how these
modulations relate to repair kinetics, cell cycle progression or which
genome is predominantly affected. Here we have investigated each of
these questions. Using highly sensitive, quantitative PCR we measured
DNA damage levels in both the nuclear DNA (nDNA) and kinetoplast
DNA (kDNA), and in BSF and PCF cells, after exposure to a range of
treatments. In doing so, we evaluated, in both life cycle forms and in
both genomes, repair kinetics of the different lesions. We also corre-
lated repair kinetics with profiles of cell cycle arrest and survival after
DNA damage. We demonstrate that DNA repair occurs in the kineto-
plast, with pronounced similarities in repair kinetics relative to the
nucleus. In addition, we show that repair kinetics and the cellular re-
sponse to damage differ dramatically between the different forms of
damage examined, and differ dramatically between BSF and PCF cells.
Taken together, these results suggest trypanosomatids can differentially
regulate the DNA damage response during growth and development.
2. Methods
2.1. Cell culture and parasite strains
Procyclic forms of T. brucei strain Lister 427 were cultivated at 27 °C
in SDM-79 media [52], supplemented with 10% heat inactivated fetal
bovine serum (Sigma), 0.2% (v/v) of hemin (Sigma) solution at 2mg
mL−1 in 0.2 M NaOH, and 1% (v/v) penicillin and streptomycin
(Sigma). Bloodstream forms of T. brucei strain Lister 427 were main-
tained at 37 °C in a humidified incubator with 5% CO2 in HMI-9 media
[53], supplemented with 10% heat inactivated fetal bovine serum
(Sigma) and 1% (v/v) penicillin and streptomycin (Sigma). CSB RNAi
knockdown and Rad51 knockout BSF strains were generated and de-
scribed previously in [29] and [51].
2.2. Parasite growth curves and treatment with genotoxic agents
BSF and PCF cells at the mid-log phase growth were harvested by
15min of centrifugation at 3000 g at 4 °C and resuspended in the same
volume of 1x PBS. For DNA photo-lesion formation, parasites re-
suspended in 1x PBS were centrifuged again for 15min at 3000 g and
4 °C and the volume of parasite suspension in 1x PBS was adjusted to
5mL. Next, parasites were spread in a small Petri plate, which was ir-
radiated with 30, 60 and 120 J/m2 of UVC light (254 nm) with a
Stratalinker® UV Crosslinker (Stratagene). Bulky DNA adducts were
induced through exposure to 50, 100, 200, and 400 μM of cisplatin in
1x PBS for one hour. Oxidative DNA damage was induced through
treatment with 50 μM of hydrogen peroxide (H2O2) in 1x PBS for
30min, and 50 and 100 μM H2O2 in 1 x PBS for one hour. Alkylating
DNA damage was induced by one hour of exposure to 0.5 and 1.5 mM
Methyl Methanesulphonate (MMS) in 1x PBS. After genotoxic treat-
ments cells were centrifuged for 15min at 3000 g at 4 °C and then re-
suspended in conditioned media (i.e the media used in the original
culture). Finally, cells were diluted 10 times and parasite growth was
monitored daily by hemocytometer counting until parasites reach sta-
tionary phase.
2.3. Detection of DNA lesions through quantitative PCR
DNA damage was quantified according to previously described ap-
proaches in mammalian cells [54] and T. brucei [29]. DNA damage was
indirectly quantified through quantitative PCR, since the amplification
yield is inversely proportional to the amount of DNA lesions. Briefly,
large fragments spanning 10 kb of either the T. brucei mitochondrial or
nuclear genome were PCR amplified, with or without prior growth in
the presence of DNA damage induction. The PCR-amplified fragment of
mitochondrial DNA was derived from the maxicircle. A small internal
fragment comprising 204 bp was used to normalize the amplification of
the larger fragments. For induction of damage, the following treatments
were used: 100 μM exposure for one hour for cisplatin or hydrogen
peroxide treatment; 30 J/m2 for UVC exposure; and 1.5 mM for one
hour for MMS damage induction. For UVC exposure, parasites were
suspended in 5mL of 1x PBS and spread in a small Petri plate. After
DNA damage induction, approximately 1×108 cells were collected at
0, 1, 2, 4 and 8 h after each treatment, centrifuged at 3000 g and 4 °C for
15min, and the resulting cell pellet immediately frozen at−80 °C. DNA
was extracted from parasite cells with the Blood & Cell Culture DNA
Mini Kit (QIAGEN), according to the manufacturer’s instructions for
DNA extraction from tissues. DNA was then quantified using PicoGreen
dye (Molecular Probes), as described by Santos et al. [54]. PCR was
performed from 15 ng of template DNA using the GeneAmp XL PCR Kit
(Applied Biosystems) and the resulting amounts of PCR product quan-
tified, again using PicoGreen and as described by Santos et al. [54]. All
PCR reactions were carried out only until the logarithmic phase, when
the amplification yields are directly proportional to the starting amount
of template. The primers used in the amplification reaction of the large
fragment in nDNA were qPCR Forward (5′-GTTGCTCACTTTCACCACG
TATTCGGGAACCTGT-3′) and qPCRReverse (5′-CCACTGAATGCTGTAT
CCGGCATTTAGTCGTGTCTATGGG-3’). To PCR-amplify the small nu-
clear fragment, used as the internal control, the primers qPCRFI (
5′-TTACAGCACCCAGGTTTATACCGCACGAAAGTGG-3′) and qPCRRe-
verse were used. To amplify the large fragment from kDNA the primers
MtF (5’-TAAGTACAAGAGGAGACAGACGACAGTGTCCACAGCAC-’) and
MtR2 (5’-TCGAACGGCTCTTTCTCTCCAGT-3’) were used. The primers
MtFI2 (5’-CCAACACTCCATTCCTGTTCACACCGTGATTCTTCTC-3’) and
MtR2 were used to amplify the mitochondrial small internal fragment.
All primers were purchased from Eurofins MWG Operon.
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2.4. Cell cycle analysis
Cell cycle analysis was performed by flow cytometry. After DNA
damage induction through exposure to 100 μM of cisplatin for one hour
or by treatment with 0.5 and 1.5mM of MMS for one hour, parasites
were centrifuged, resuspended in conditioned media and cultivated for
recovery at different time points as indicated in results section. At each
time point, approximately 0.5–1×106 cells were harvested, washed
once in 1x PBS and suspended in fixation solution containing 70%
methanol and 30% PBS. Cells were then kept at 4 °C overnight to sev-
eral days, according to each experiment time course. Cells were washed
in 1mL of cold 1x PBS and resuspended in 1ml of 1 x PBS containing
10 μg ml−1 propidium iodide (PI) and 10 μg ml−1 RNaseA. Cells were
then incubated at 37 °C for 45min and flow cytometry was performed
with a Becton Dickinson FACScan, using detector FL2-A and a total of
10,000 events. Data were analyzed with FlowJo v10™ software.
2.5. FITC annexin V assay
To perform the FITC Annexin V assay we treated the parasites with
cisplatin and MMS. For MMS treatment, parasites were exposed to 0.5,
1.0 and 1.5mM of MMS for one hour and immediately analyzed by
FACS. For cisplatin treatment, cells were incubated for one hour with
100, 200 and 400 μM of cisplatin and analyzed by FACS 24 h after DNA
damage induction. For FACS analysis, approximately 0.5–1×107 cells
were harvested and washed in cold 1x PBS and resuspended in 500 μL
of 1x annexin-binding buffer (10mM HEPES, 140mM NaCl, 2.5mM
CaCl2, pH 7.4), containing 200 ng mL−1 of PI and 5 μL of FITC annexin
V (Invitrogen). After incubation for 5min, cells were analyzed by flow
cytometry in a total of 5000 events and using detectors for FL1-H and
FL2-H, which detect respectively FITC annexin V and PI fluorescence.
Control cells used to set up compensation and quadrants were washed
in 1x PBS, fixed in 70% ethanol and labeled with IP and/or FITC
Annexin V according described above. Data were analyzed using
FlowJo v10™ software.
2.6. Statistical analysis
All statistical analyses were performed with the software GraphPad
Prism version 6.01.
3. Results
3.1. BSF T. brucei cells display higher efficiency than PCF cells in repair of
DNA adducts induced by cisplatin
We previously showed that BSF T. brucei present high efficiency
repair of nDNA damage induced by cisplatin, and that the proficiency of
removal of cisplatin-induced adducts in BSF cells relies on transcrip-
tion-coupled NER [29]. Here, we used the same approach to measure
the level of damage induction and kinetics of repair in PCF nDNA after
exposure to cisplatin. In addition, we monitored damage induction and
repair in the kDNA of both T. brucei life stages. We first performed a
dose response curve in BSF cells, with doses ranging from 50 to 400 μM
of cisplatin for one hour, to select which dose will induce>1 lesion/
10 kbp (Fig. 2A). Treatment with 100 μM of cisplatin induced ∼1.5
lesions/10 kbp after 1 h in the nDNA of both life cycle forms, without
inducing high levels of cell death 10 h after treatment (Figs. 2A and
S1 A). However, the levels of adducts induced by cisplatin were higher
in nDNA than in kDNA at all concentrations tested, with∼0.5 lesions/
10 kbp of kDNA at 100 μM (Fig. 2A). We next compared the kinetics of
cisplatin lesion repair in both life stages of T. brucei. Within the first
hour post-treatment BSF cells removed essentially all lesions in the
regions analyzed in both the nDNA (Fig. 2B) and kDNA (indeed, at this
time point kDNA lesion levels were even lower than the basal level of
kDNA damage; Fig. 2C). Conversely, in PCF cells only half of nDNA
lesions were removed throughout the entire 8 h of time course (Fig. 2B),
and the level of lesions in the kDNA did not reduce to basal levels of
damage (Fig. 2C). Therefore, though both life stages of T. brucei can
repair cisplatin-induced adducts, lesion removal occurs from either the
nDNA or kDNA more efficiently in BSF cells than in PCF. Previously, we
demonstrated that the rapid repair of cisplatin in BSF T. brucei contrasts
with the slow kinetics of UVC-induced DNA damage repair [29]. To ask
if slow UVC lesion repair is only seen in BSF cells, we compared nDNA
and kDNA repair kinetics in the two life cycle stages (Fig. S2). In both
BSF and PCF cells UVC lesion removal was either slower than that of
similar levels of cisplatin lesions (nDNA), or was not detectable in the
time course (kDNA). Thus, both life cycle forms of the parasite have a
limited capacity to repair these levels of nuclear UVC damage and an
even lower capacity to repair UVC damage to the kinetoplast.
3.2. Repair of oxidative damage is more effective in BSF than in PCF
Base excision repair (BER) tackles oxidative DNA damage in T.
brucei [32], though further work suggests MMR may also act [42–44].
To induce oxidative damage and examine repair efficiency of the re-
sulting lesions we exposed both life cycle forms of the parasite to hy-
drogen peroxide. To select an ideal dose we treated BSF cells with
hydrogen peroxide concentrations ranging from 50 to 400 μM for 15
(data not show) and 60min (Fig. 3A). No damage induction could be
detected by PCR at any of the doses tested over 15min (data not show).
However, treatment with 100 μM hydrogen peroxide for one hour in-
duced ∼1.5 lesions/10 kbp in the nDNA of both BSF and PCF cells
(Fig. 3A, B), without significantly decreasing parasites survival 10 h
after treatment (Fig. S1B). In contrast to cisplatin-induced damage,
both BSF or PCF cells displayed relatively slow repair of oxidative da-
mage in the nDNA: in each case reduction in the levels of PCR-blocking
lesions occurred, but did not approach returning to basal levels of da-
mage (Fig. 3B). Unlike in the nDNA, we could not detect damage in-
duction in the kDNA of either BSF or PCF cells following exposure to
hydrogen peroxide (Fig. 3A). However, increased levels of damage
emerged in the time points following exposure (Fig. 3C), indicating that
DNA damage induced by hydrogen peroxide in kDNA is caused in-
directly. Moreover, such indirect damage induction arose more rapidly
in PCF cells than in BSF, and was more slowly removed, since only in
BSF cells did the levels of PCR-blocking lesions reduce in the kDNA to
near basal levels during the time course analyzed (Fig. 3C).
3.3. BSF and PCF T. brucei cells display distinct patterns of induction and
repair of lesions caused by MMS
Since trypanosomatid NER targets cisplatin-induced adducts more
efficiently than photolesions [29], and T. brucei repairs DNA oxidative
damage with relatively low efficiency (Section 3.2), we next in-
vestigated how the parasite handles DNA alkylating damage. In most
model organisms MMS damage is repaired by BER, though further re-
pair pathways have also been implicated, including MMR and HR
[55,56]. BSF and PCF cells displayed highly divergent sensitivity in the
first hours after treatment with 1.5–6mM MMS (Fig. S1C) and so, in
order to select an appropriate dose to compare repair kinetics, we
performed separate dose response curves in the two life cycle forms
(Fig. 4A, B). Consistent with the different MMS sensitivities (Fig. S1C),
we found that the pattern of MMS dose response, for both nDNA and
kDNA, differed in BSF and PCF cells, and that different doses of MMS
were necessary to induce similar levels of PCR-blocking lesions (Fig. 4A,
B). A dose of 1.5mMMMS for one hour induced∼1.5 lesions/10 kbp in
the nDNA of BSF (Fig. 4A), whereas 3mM for one hour was needed to
get the same lesion frequency in the nDNA of PCF cells (Fig. 4B).
The dynamics of MMS-induced lesion repair was markedly different
in the two life cycle stages of T. brucei (Fig. 4A, B). BSF cells presented a
complex pattern of repair, where the amount of PCR-blocking DNA
damage in both nDNA and kDNA dropped rapidly within one hour after
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treatment, and then increased from 2 to 5 h, reaching a similar level of
damage to that observed at the beginning of the recovery period. from 4
to 8 hours, the level of DNA damage then reduced again, returning to
near basal levels 8 h after treatment. Thus, there appears to be two
distinct phases of MMS-induced damage repair in BSF T. brucei: early
repair, which occurs within the first hour after treatment, and late re-
pair, which happens from 4 to 8 h (Fig. 4C, D). In striking contrast to
the BSF cells, and consistent with the results obtained in the dose re-
sponse curve, the treatment of PCF cells with 1.5 mM MMS does not
induce detectable DNA damage either in nDNA or kDNA. However,
there was a subtle increase in the level of lesions from 0 to 8 hrs (Fig. 4C
and D). Taken together, these MMS data add to that described in Sec-
tions 3.1 and 3.2 and confirm substantial differences in DNA damage
repair between BSF and PCF T. brucei cells, as well as strikingly
Fig. 2. Induction and repair of cisplatin-induced DNA damage in nuclear DNA (nDNA) and kinetoplast DNA (kDNA). A) Dose response curve of lesions in
nDNA (traced line with circles) and kDNA (full line with squares) of BSF cells as a function of cisplatin doses. Cells were treated with 50 to 400 μM of cisplatin for 1 h.
B) DNA repair kinetics of nDNA from BSF (traced line with circles) and PCF (full line with squares) cells after treatment with 100 μM of cisplatin for 1 h. C) DNA
repair kinetics of kDNA from BSF and PCF cells treated as described in (B). Negative values of lesions indicate that the frequency of lesions/10 kb is lower than the
basal level. The data were obtained from two independent PCR amplifications derived from each of the two biological duplicates. Data were analyzed using Two-way
ANOVA repeated measures with fixed effects for cell type, time, and their interaction. This analysis was followed by Sidak’s multiple comparisons post test. Error bars
denote standard deviation and **, ***, and **** mean respectively p values less than 0.01, 0.001, and 0.0001.
Fig. 3. Measurement of DNA damage and repair of lesions caused by hydrogen peroxide treatment. A) Dose response curve of DNA lesions induced by
hydrogen peroxide in nDNA (traced line with circles) and kDNA (full line with squares) of BSF cells. Cells were treated with 50, 100, 200, and 400 μM of hydrogen
peroxide for 1 h. Repair kinetics of oxidative damage in nDNA (B) and kDNA (C) of BSF (traced lines with circles) and PCF (full lines with squares) cells treated with
100 μM of hydrogen peroxide for 1 h. Negative values of lesions indicate lower frequency of DNA damage relative to the untreated control. The data were obtained
from two independent PCR amplifications derived from each of the two biological duplicates. Error bars denote standard deviation and *, **, and **** mean
respectively p values less than 0.05, 0.01, and 0.0001 calculated by Two-way ANOVA repeated measures with fixed effects for cell type, time, and their interaction,
followed by Sidak’s multiple comparisons post test.
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different patterns of repair for the three forms of damage examined.
3.4. TbCSB is involved in the parasite response to MMS, while TbRad51 is
required for the late processing of DNA alkylating damage
One explanation for the complex pattern of DNA repair during the
removal of MMS-induced damage in BSF cells is that two (or more)
DNA repair pathways can remove DNA alkylating damage in T. brucei.
Most cells studied to date repair MMS-alkylated bases by BER.
However, the deletion of APE1, which plays a key role in BER by
cleaving the sugar phosphate backbone at the 5’ end of an abasic site,
does not increase BSF T. brucei sensitivity to MMS [32], suggesting a
crosstalk between BER and other repair pathways. To ask whether other
proteins than those enrolled in canonical BER could have a role in the
repair of alkylating DNA damage in BSF T. brucei, we compared the
sensitivity of BSF T. brucei cells to MMS before and after RNAi-mediated
knockdown of TbCSB, a component of transcription-coupled NER [29].
Cells in which RNAi against CSB had been induced displayed increased
sensitivity to MMS compared with uninduced cells at three concentra-
tions of MMS when growth was evaluated in BSF cells in the 10 h fol-
lowing exposure (Fig. 5A), suggesting involvement of TbCSB in the
repair of MMS-alkylation lesions in T. brucei BSF cells.
Unrepaired lesions or repair intermediates that persist until S phase
might block DNA replication, leading to replication fork collapse and,
potentially, DSB induction [56]. To test whether T. brucei HR con-
tributes to the complex pattern of MMS repair, we evaluated the repair
efficiency and sensitivity of a BSF RAD51 null mutant strain (rad51 -/-)
after induction of MMS damage. RAD51 absence altered the profile of
nDNA lesion removal, appearing not to impede the early (up to 1 h)
repair but to prevent the removal of lesions that accumulated later,
suggesting HR acts in the late repair (Fig. 5D). Consistent with this,
survival of rad51-/- cells up to 10 h after exposure to two concentra-
tions of MMS was not notably different from wild type cells (Fig. 5B),
but survival of the null mutants was drastically curtailed when growth
was measured at the same MMS doses over 150 h (Fig. 5C). In the PCR
repair assay (Fig. 5D), it was notable that nDNA lesions remerged from
1 to 2 hours in both the wild type and rad51-/- cells, suggesting either
that some MMS lesions are not repaired during the first hour and ac-
cumulate thereafter, or the incomplete repair of these lesions will lead
to more severe consequences, such as DSBs formation. Irrespective, the
data are consistent with a role for RAD51 only in the late step of repair
of nDNA lesions induced by MMS, perhaps when the BSF cells enter S-
phase.
The above data reveal a role for RAD51 in the late repair of DNA
alkylating damage in BSF nDNA. To evaluate whether RAD51 is also
involved in repair in the kDNA of BSF cells, we monitored damage
induction and repair by the kDNA PCR assay, treating rad51 -/- cells-
with 0.5mM MMS for one hour. Here, the absence of RAD51 affected
only the late step of the repair of MMS-induced damage, presenting a
similar pattern to what we observed in the repair of nDNA (Fig. 5E).
These data indicate a role for RAD51 in the maintenance of kDNA in-
tegrity in BSF T. brucei.
3.5. BSF T. brucei cells show higher sensitivity to DNA damage than PCF
cells
In the data above (Sections 3.1 and 3.2) we show that exposure to
cisplatin or hydrogen peroxide induces similar levels of DNA damage in
both T. brucei life stages. However, BSF cells show higher efficiency
than PCF cells in repairing cisplatin and hydrogen peroxide-induced
DNA damage. Though higher doses of MMS were needed in PCF cells to
induce similar levels of damage to that seen in BSF cells, there was
greater evidence of active repair in the latter life cycle stage (Section
3.3). To test if the higher efficiency of BSF DNA repair is reflected in
greater cell survival relative to PCF cells, we induced DNA damage
using the time-limited exposure approaches employed in the DNA re-
pair assays and then we evaluated recovery of cell growth. Despite the
higher DNA repair efficiency of damage induced by the treatments with
cisplatin and hydrogen peroxide, BSF cells displayed substantially
higher cell death rates than PCF cells (Fig. 6A–D). The MMS treatment
used induces higher level of DNA damage in BSF cells than in PCF, and
resulted in hugely accentuated death and growth impairment in the
former life cycle stage (Fig. 6 E, F). Thus, we conclude that BSF cells
invariably display higher cell death rates regardless of the damage level
Fig. 4. Assessment of formation and repair of alkylating DNA damage in BSF and PCF cells treated with MMS. Lesions frequencies in nDNA (traced lines with
circles) and kDNA (full lines with squares) of BSF (A) and PCF (B) cells as a function of MMS dose (mM). BSF cells were treated with 0.5 to 2mM of MMS for 1 h
whereas PCF cells were treated with 1.5–12mM of MMS for 1 h. DNA repair kinetics of MMS-induced lesions in nDNA (C) and kDNA (D) of BSF (traced lines with
circles) and PCF (full lines with squares) cells treated with 1.5 mM of MMS for 1 h. The data were obtained from two independent PCR amplifications derived from
each of two biological duplicates. Error bars denote standard deviation. *** and **** mean respectively p values less than 0.001 and 0.0001 calculated by Two-way
ANOVA repeated measures with fixed effects for cell type, time, and their interaction, followed by Sidak’s multiple comparisons post test.
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or lesion type induced in the T. brucei genome(s).
3.6. BSF and PCF T. brucei cells undergo cell cycle arrest or perturbation
after DNA damage
BSF and PCF T. brucei cells present different DNA repair efficiencies
and different cell survival rates upon damage induction by the three
genotoxic agents examined. To test whether differential regulation of a
DNA damage checkpoint would account for the distinct outcomes
presented by BSF and PCF cells, we evaluated their cell cycle patterns
by flow cytometry after exposure to MMS and cisplatin (Fig. 7). The cell
cycle distribution of asynchronous populations of both life cycle stages
were altered by both forms of DNA damage. After cisplatin treatment,
both BSF and PCF cells displayed a loss of 2n cells and an increase in 4n,
indicating both had accumulated in the G2/M phase of cell cycle (Fig. 7
A, B).
BSF and PCF cells both accumulated in S phase (DNA content be-
tween 2n and 4n) after MMS treatment. However, though BSF cells
remained arrested in S phase for only 12 h, PCF cells displayed a longer
S-phase accumulation, with increased 2n-4n DNA seen at 24 h. These
results suggest that the timing of the cell cycle response to alkylation
damage differs in the two life stages (Fig. 7C and D). In addition, though
we are able to observe recovery of a normal cell cycle distribution of
PCF cells after treatment with cisplatin and MMS (Fig. S3), we could not
track BSF cell recovery by flow cytometry experiments because of their
high death rates, further indicating a differing cell cycle response in the
two life cycle forms.
Taken together, these data suggest that, despite differing repair and
growth profiles after cisplatin DNA damage, BSF and PCF cells may
activate similar putative checkpoint responses, though with differing
long term consequences. In contrast, MMS damage elicits distinct re-
pair, growth and cell cycle responses in the two life cycle stages. Thus,
these data reveal differing DNA damage responses and, potentially,
divergent cell fates in BSF and PCF cells after genome damage.
3.7. PCF and BSF T. brucei cells undergo distinct cell death pathways upon
DNA damage induction
Cell death in mammals can be classified as regulated or unregulated
depending on several biochemical and morphological features.
Regardless of the ongoing debate regarding whether or not trypano-
somatids can induce cell death by apoptosis or programmed cell death,
Fig. 5. CSB and RAD51 act in the response to T. brucei MMS-induced DNA damage. A) Survival curve analysis of BSF cells 10 h after the treatment with
0.5–2mM of MMS for 1 h in the presence and absence of TbCSB RNAi-mediated knockdown. B) Survival curve analysis of BSF rad51 -/- cells 10 h after the treatment
with 0.5–1.5 mM of MMS for 1 h. C) Analysis of BSF rad51 -/- cells grown for 10 to 144 h after treatment with 0.5 and1.5mM of MMS for 1 h. Values are the means of
three independent experiments, and error bars denote standard deviation. DNA repair kinetics of MMS-induced lesions from nDNA (D) and kDNA (E) of BSF rad51 -/-
cells (full lines with squares) treated with 0.5 mM of MMS for 1 h. The data were compared and plotted together with results previously presented in Fig. 4 C, D of
repair curves in nDNA and kDNA from BSF wild type (wt) cells (traced lines with circles) treated with 1.5mM of MMS for 1 h. The data were obtained from two
independent PCR amplifications derived from each of two biological duplicates. Error bars denote standard deviation. A Two-way ANOVA repeated measures with
fixed effects for cell type, time, and their interaction followed by Sidak’s multiple comparisons post test were used to analyze the DNA repair data, p< 0.01, 0.001
and 0.0001 (**, *** and ****).
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these organisms present more than one pathway of cell death, which
have been classified as necrosis and incidental cell death, with the latter
pathway sharing some features with intrinsic apoptosis, such as phos-
phatidylserine (PS) exposure, nuclear DNA fragmentation, and loss of
mitochondrial membrane potential. Because the molecular machinery
of intrinsic apoptosis has not been identified in trypanosomatids, this
particular cell death mechanism is classified as incidental cell death and
grouped together with all other cell death pathways which differ from
unregulated necrosis [57]. To ask if different cell death pathways arise
in BSF and PCF T. brucei cells after DNA damage induction we mon-
itored parasite cell death through propidium iodide (PI) and FITC An-
nexin V staining after treatment with MMS and cisplatin. Annexin V has
strong affinity to phosphatidylserine (PS), which is present in the outer
face of the plasma membrane of cells undergoing apoptosis. Therefore,
we classified FITC Annexin V positive cells as undergoing incidental cell
death and double positive cells (Annexin V and PI-positive) as necrotic
cells, whereas double-negative cells indicates vital cells [58]. After both
types of damage, BSF cells presented greater PS exposure than PCF
cells, suggesting higher occurrence of incidental cell death in the former
than in the latter (Fig. 8). Thus, the data suggest greater levels of cell
death associated with PS exposure in BSF cells than in PCF upon in-
duction of DNA damage, which may be explained by the differing
growth responses of the two cell types, as well as by the differing cell
cycle changes after MMS exposure.
4. Discussion
In this study, we have analyzed T. brucei DNA repair in both gen-
omes of the parasite (nDNA and kDNA), and in two replicative life
stages after DNA damage induction. The data reveal active repair of
genome damage in both organelles, though repair kinetics were not
equivalent in the two genomes. In addition, strikingly different repair
kinetics for DNA damage are seen in the two life cycle stages examined,
as well as diverged growth responses, some of which can be explained
by variant cell cycle responses. After three forms of damage - oxidation,
alkylation and DNA crosslinking - mammal-infective T. brucei cells
display greater cell death than tsetse-infective cells.
Cisplatin, hydrogen peroxide and MMS generate distinct forms of
DNA damage, which appear to be tackled in different ways in T. brucei.
The parasite appears to be highly efficient in repairing cisplatin-in-
duced DNA damage, as the kinetics of lesion removal were markedly
fastest for this genotoxic agent. Indeed, cisplatin damage repair in T.
brucei appears faster than in human cells, which (when analyzed using
the same PCR technique) do not remove more than 50% of cisplatin
adducts present in a transcriptionally active gene within 24 h [59]. One
explanation is that failure to rapidly tackle DNA cross-links would be
highly deleterious to T. brucei, given its near universal use of multigenic
transcription. In contrast to cisplatin, though T. brucei can repair oxi-
dative damage, the efficiency of the reaction is lower, which again
contrasts with human fibroblasts, which can repair most oxidative da-
mage in nDNA within 1.5 h [60]. Finally, we found that BSF T. brucei
presents a complex pattern of repair of MMS-induced damage. This
pattern may correspond with the rapid DNA synthesis inferred by mi-
crofluorometry analysis of nDNA and kDNA in T. b. gambiense treated
with bleomycin [61]. Though bleomycin can cause DSBs, it can also
induce abasic sites, the first intermediate that occurs after removal of an
alkylated base [62]. In contrast to BSF cells, PCF cells were resistant to
higher levels of MMS, which might suggest PCF cells possess a more
effective detoxification mechanism or perhaps can directly revert al-
kylating DNA damage.
The number of lesions induced after exposure to MMS, cisplatin or
hydrogen peroxide in kDNA, within the same parasite life stage, was
always lower than in nDNA. Moreover, the repair of cisplatin-induced
adducts in kDNA appeared more effective than in nDNA. In this regard,
T. brucei presents the opposite pattern of nuclear versus mitochondrial
DNA repair when compared to human cells, where mitochondrial DNA
lesions caused by hydrogen peroxide are more extensive and persistent
than nuclear lesions localized [60]. Though lesions caused by MMS are
not more extensive in human mitochondrial DNA relative to nuclear
DNA, they last much longer [63], whereas MMS-induced lesions appear
to be tackled at similar rate in the nucleus and kinetoplastid of T. brucei.
Thus, T. brucei appears to encode efficient kDNA repair. Though mito-
phagy or DNA ejection resulting from kDNA damage has not been de-
scribed in T. brucei, viable akinetoplastic/diskinetoplastic (total/partial
loss of kDNA) BSF cells can be induced by the treatment with DNA
intercalators [64]. However, akinetoplastic/diskinetoplastic BSF cells
are only viable due to compensatory mutations in the nuclear encoded
F1/F0 ATPase subunit γ [65]. In insect-derived forms, kDNA loss in-
duced by chemical treatment results in non-viable parasites [64].
Therefore, the maintenance and repair of kDNA seems to play an es-
sential role during most, if not all, of the parasite life cycle. Indeed, the
T. brucei nDNA and kDNA repair curves were very similar for some
Fig. 6. Growth curves of BSF and PCF cells after treatment with cisplatin, hydrogen peroxide, and MMS. A) BSF cells treated with 0 (circles), 100 (squares),
200 (triangles), and 400 μM (inverted triangles) of cisplatin for 1 h. B) PCF cells treated as described in (A). C) BSF cells treated with 0 (circles), 50 μM of hydrogen
peroxide for 30min (squares), 50 μM for 60min (triangles), and 100 μM for 60min (inverted triangles). D) PCF cells treated as described in (C). E) BSF cells treated
with 0 (circles), 0.5 (squares), and 1.5 (triangles) mM of MMS for 1 h. F) PCF cells treated as described in (E). Data are the means of three independent experiments
and error bars represent standard deviation.
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Fig. 7. Cell cycle analysis by flow cytometry of asynchronous log-phase BSF and PCF cell populations after DNA damage induction. A) Representative
histograms of BSF (left column) and PCF (right column) cells with no treatment (Untreated) and 24 h after treatment with 100 μM of cisplatin for 1 h (Cisplatin –
24 h). B) Quantification of (A). C-) BSF (left column) and PCF (right column) cells with no treatment (Untreated) and 12 and/or 24 h after treatment with 1.5 mM of
MMS for 1 h (MMS – 12/24 h). D-) Quantification of (C). FACS analysis was performed on 10,000 cell counts (y axis). The channel FL2-A (x axis) was used to detect
propidium iodide staining and therefore to quantify DNA content. Asterisks denote p values less than 0.05 calculated by chi-square test; n.s.= not significant.
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cisplatin and MMS damage, suggesting multiple DNA repair pathways
act to promote stability of both genomes. Trypanosomatid kDNA is an
interlinked network of minicircle and maxicircle concatemers, which
requires several proteins for its maintenance, most of which have been
associated with replication [48]. Information regarding what DNA re-
pair pathways are present in trypanosomatid mitochondria is more
limited and, based on the work here, merits further investigation. For
instance, no study has so far attributed a role for RAD51 in trypano-
somatid kDNA metabolism, in contrast to several studies describing the
role of RAD51 in parasite nDNA repair [13,14,51,66]. Though im-
munofluorescence has only detected RAD51 in the nucleus of T. brucei
[14,51,66], the PCR assay here demonstrates impaired repair of MMS
damage in the kDNA of RAD51 mutants. What role TbRAD51 provides
is unclear, but recombination-assisted DNA replication is a common
theme of catenated DNA [67], such as mitochondrial DNA from yeast
[68] and human cardiac cells [69].
NER repairs helix distorting DNA lesions and is subdivided in GG-
NER, which targets DNA lesions genome wide, and TC-NER, which
targets DNA damage that impedes transcription [70]. As noted above,
transcription in trypanosomatids is unusual, in that virtually all genes
are encoded initially as multigene transcripts, meaning most of the
genome is traversed by RNA polymerase. Consistent with this, T. brucei
NER shows specialization because, amongst the genes tested for func-
tion, only the TC-NER genes TbCSB, TbXPBz and TbXPG have been
shown clearly to act in NER. In contrast, the GG-NER genes TbXPC and
TbDDB appear to function in inter-strand cross link repair [29]. This
NER specialization probably explains the rapidity by which cisplatin
adducts are repaired, with TbCSB likely to act as the main regulator,
evoking TC-NER-mediated repair of cisplatin lesions that block RNA
Polymerase [29]. In fact, the involvement we now describe for TbCSB in
tackling MMS damage suggests that maintaining transcription is
crucial, with TbCSB having been co-opted to repair alkylation DNA
damage. Alkylated bases are classically targeted by BER through the
action of DNA glycosylases, thus generating abasic sites that, if handled
by short-patch BER, will be processed by the sequential action of an AP
endonuclease (APE1), DNA polymerase β, and a DNA ligase [55].
However, mutation of APE1 in BSF T. brucei does not change the
parasite’s sensitivity to MMS and temozolomide [32], suggesting BER
adaptations in trypanosomatid repair of alkylated bases. In this case,
one possible hypothesis is that TbCSB could promote the repair of
transcription-blocking BER intermediates by recruiting the BER scaffold
protein XRCC1, as suggested to occur in human cells [71], thus facil-
itating the repair of damaged bases. However, no XRCC1 homolog is
found in trypanosomatids, perhaps suggesting other mechanistic
adaptations. Alternatively, alkylating DNA damage can be repaired by
NER itself, since 8-oxoguanine can be removed by TC-NER [72].
Moreover, CSB can stimulate several DNA glycosylases [73] and APE1
[74], and yeast NER can tackle abasic sites [75]. Thus, there is pre-
cedence for crosstalk between BER and NER and it is possible this has
assumed greater prominence in trypansomatids due to their novel
transcription strategies.
Excision repair intermediates, such as abasic sites or gaps, are even
more toxic than the initial lesion, because they cause collapse of the
replication fork, perhaps leading to the formation of DSBs [56]. The
absence of RAD51 in BSF T. brucei impacts only on the late steps of
MMS-induced nDNA damage repair, with lesions accumulating from 4
to 8 hours rather than being removed (as occurs in wild type cells). This
effect, allied to the pronounced increase of MMS- induced lesions in
wild type BSF cells from 2 to 5 hours relative to rad51 -/- cells suggests
a complex picture of alkylation repair in these cells. A feasible model is
that in wild type cells alkylating DNA damage is tolerated if in-
completely repaired until DNA replication occurs, when RAD51
Fig. 8. Flow cytometry analysis of asynchronous log-phase populations in the presence and absence of DNA damage by FITC Annexin V and propidium
iodide staining. A) Top row: BSF cells with no treatment and immediately after exposure to 0.5, 1.0 or 1.5 mM of MMS for 1 h. Bottom row: PCF cells 24 h after
treatment with 0. 1.0 or 1.5 mM of MMS for 1 h. B) Quantification of A-). C)Top row: BSF cells with no treatment and 24 h after treatment with 100, 200 or -400 μM
of cisplatin for 1 h. Bottom row: PCF cells treated and analyzed as described in the top row. D) Quantification of C-). FACS analysis was performed on 5000 cell
counts. Channels FL2-H (y axis) and FL1-H (x axis) were used to detect, respectively, propidium iodide (PI) and FITC-Annexin V (Annexin-V) staining. Asterisks
denote p values less than 0.05 calculated by chi-square test.
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promotes tolerance in S phase. After replication, most of the damage is
successfully repaired either by excision repair or HR. In RAD51
knockout cells, HR capacity is presumably severely impaired. There-
fore, excision repair which is otherwise counteracted by RAD51, takes
place at S phase and causes a delay in DNA replication. After S phase,
and in the absence of HR, under-replicated sites arising from impaired
DNA replication will contribute to DSBs formation and genomic in-
stability. Consistent with this model, RAD51 from yeast prevents the
repair of gaps left behind the replication fork to avoid spurious HR
reactions in S phase, but assures proper HR-based repair of these gaps
after DNA replication and S phase are concluded [76]. Therefore, such a
mechanism of damage tolerance performed by HR in yeast and other
eukaryotic lineages [77] might be also conserved among trypanoso-
matids.
In addition to the differing strategies of DNA protection and repair
used by BSF and PCF cells in response to damage induced by alkylation,
DNA repair of cisplatin and hydrogen peroxide lesions, which are po-
tentially repaired by NER and BER, is more efficient in BSF T. brucei
than in PCF. Regulation of DNA repair is well established when the
choice of repair pathway used depends on the cell cycle phase. Upon
DSB formation, for example, NHEJ is predominantly enacted when a
yeast or mammalian cell is in the G1 phase, while HR predominates in
S/G2 phases [78]. In contrast, DNA repair regulation depending on cell
type or cell differentiation is less understood. However, mammalian
embryonic stem cells are known to repair DSBs through HR and present
a high capacity to perform NER and BER pathways, whereas post-mi-
totic cells use NHEJ to repair DSBs and downregulate excision repair
[79,80]. PCF and BSF T. brucei cells present different cell cycle
checkpoints even in non-damaging conditions: PCF cells can proceed to
cytokinesis despite a blockage in S phase or mitosis, but in BSF cells
inhibition of mitosis impedes cytokinesis but cannot block new rounds
of DNA replication [9,10]. How these checkpoints relate to DNA da-
mage conditions has been little examined, despite recent descriptions of
multiple protein kinases that respond to MMS-induced damage [49].
Both life cycle forms of T. brucei present similar patterns of G2/M cell
cycle arrest following cisplatin exposure, perhaps indicating they share
the same mechanism of checkpoint signaling. In contrast, though both
BSF and PCF cells accumulate in S-phase after MMS treatment, BSF cells
remain arrested in this cell cycle phase for less time. In response to both
forms of damage, cell death appears to be more pronounced in BSF cells
(as determined by growth and flow cytometry), whereas PCF cells ap-
pear to show a greater capacity for cell growth arrest. Protein networks
involved in sensing and signaling DNA damage, thus halting the cell
cycle and dictating cell fate, can vary amongst distinct cell types be-
longing the same organism. Mammalian embryonic stem cells, for in-
stance, present an unusual bypass of the G1 checkpoint and a lower
threshold to trigger apoptosis, while post-mitotic cells have a fully ac-
tive checkpoint and restrict apoptosis [79,80]. Caenorhabditis elegans
also pursues differential patterns of response to DNA damage, with
germ line cells having higher efficiency DNA repair and being more
prone to undergo apoptosis than somatic cells [81,82]. Taken together,
we hypothesize that BSF T. brucei may share more features of the DNA
damage response with stem cells, while PCF T. bruceimore resemble the
strategies of adult post-mitotic cells to cope with DNA damage. We
suggest that BSF cells are programmed to perform fast DNA replication
by deactivating at least some checkpoint signaling. To compensate for
this checkpoint deactivation, and to avoid the deleterious effects of
replicative stress, BSF cells upregulate DNA repair. However, in con-
ditions of extreme DNA damage repair can be overwhelmed, with cells
accumulating in G2/M as they encounter unrepaired blocks to re-
plication, which are then lethal as the cell continues to undergo mitosis.
It is conceivable that this strategy stems from growth requirements in
the mammal: if VSG switching is intimately associated with DNA re-
plication, then there will be pressure to prioritize replication in order to
sustain the infection in the face of the mammalian immune response. In
contrast, upon differentiation to the PCF, T. brucei appears to reactivate
DNA damage checkpoint(s), allowing replication to be paused until
DNA repair is accomplished. Here, cell death or senescence would be
less frequent and only occur when DNA repair fails to restore genome
integrity.
In summary, we suggest that developmental regulation of the DNA
damage response in T. brucei can account for the different repair phe-
notypes described here for BSF and PCF cells, and for the differing re-
pair and growth phenotypes of DNA repair gene mutants in the two life
cycle stages [43,50,51]. To date, differential use of the DNA damage
response has mainly been considered in the context of cell differentia-
tion during the development of multicellular organisms [79,80,82]. We
show here that the DNA damage response can be varied depending on
the developmental stage of a unicellular organism. We cannot trace a
direct parallel between the molecular mechanisms of DNA damage re-
sponse regulation from T. brucei to multicellular organisms, despite
extensive conservation of the T. brucei DNA repair machinery, because
of lack of conservation of canonical mechanisms of programmed cell
death in the protozoan parasite [57], as well as limited understanding
of the signaling events that co-ordinate DNA repair during the T. brucei
cell and life cycle. Further studies will be necessary to determine the
cellular mechanisms that regulate the DNA damage response in T. brucei
and related, early branching eukaryotes.
5. Conclusions
Mammal and insect-derived T. brucei life cycle cells present different
DNA repair efficiencies and distinct cellular responses to DNA damage,
indicating developmental regulation of the DNA damage response. DNA
repair is active in the T. brucei mitochondrial genome, with similar
kinetics to nuclear repair. RAD51 promotes maintenance of the T. brucei
mitochondrial genome.
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